Magnetic Intracellular Labeling of Mammalian Cells by Combining (FDA-Approved) Superparamagnetic Iron Oxide MR Contrast Agents and Commonly Used Transfection Agents
Top Cited Papers
- 1 February 2002
- journal article
- research article
- Published by Elsevier BV in Academic Radiology
- Vol. 9 (2), S484-S487
- https://doi.org/10.1016/s1076-6332(03)80271-4
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Synthesis and Characterization of Soluble Iron Oxide−Dendrimer CompositesChemistry of Materials, 2001
- Mesenchymal stem cells: Biology and potential clinical usesExperimental Hematology, 2000
- Stem cells — hype and hopeNature, 2000
- Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cellsNature Biotechnology, 2000
- Neurotransplantation of magnetically labeled oligodendrocyte progenitors: Magnetic resonance tracking of cell migration and myelinationProceedings of the National Academy of Sciences of the United States of America, 1999
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- High-Efficiency Intracellular Magnetic Labeling with Novel Superparamagnetic-Tat Peptide ConjugatesBioconjugate Chemistry, 1999
- Derivation of pluripotent stem cells from cultured human primordial germ cellsProceedings of the National Academy of Sciences of the United States of America, 1998
- Embryonic Stem Cell Lines Derived from Human BlastocystsScience, 1998
- Characterization of Complexes of Oligonucleotides with Polyamidoamine Starburst Dendrimers and Effects on Intracellular DeliveryJournal of Pharmaceutical Sciences, 1997